Page 266 - Haematologica Vol. 107 - September 2022

LETTER TO THE EDITOR
SIRIUS trials. Lancet Haematol. 2020;7(6):e447-e455.
11. Sharma M, Zhang MJ, Zhong X, et al. Older patients with
myeloma derive similar benefit from autologous transplantation. Biol Blood Marrow Transplant. 2014;20(11):1796-1803.
12. Hari PN, Majhail NS, Zhang MJ, et al. Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma. Biol Blood Marrow Transplant. 2010;16(3):395-402.
13. Ailawadhi S, Parikh K, Abouzaid S, et al. Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysis. Blood Adv. 2019;3(20):2986-2994.
14. Verma PS, Howard RS, Weiss BM. The impact of race on outcomes of autologous transplantation in patients with multiple myeloma. Am J Hematol. 2008;83(5):355-358.
15. Sun L, Li S, El-Jawahri A, et al. Autologous stem cell transplantation in elderly lymphoma patients in their 70s:
outcomes and analysis. Oncologist. 2018;23(5):624-630. 16. Tao L, Foran JM, Clarke CA, Gomez SL, Keegan THM.
Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era. Blood. 2014;123(23):3553-3562.
17. Shenoy PJ, Malik N, Nooka A, et al. Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States. Cancer. 2011;117(11):2530-2540.
18. Neighborhood Profiles: The Bronx BX: NYU Furman Center; https://furmancenter.org/neighborhoods/view/the-bronx
19. Chamoun K, Firoozmand A, Caimi P, et al. Socioeconomic factors and survival of multiple myeloma patients. Cancers (Basel). 2021;13(4):590.
20. Koroukian SM, Bakaki PM, Raghavan D. Survival disparities by Medicaid status: an analysis of 8 cancers. Cancer. 2012;118(17):4271-4279.
Haematologica | 107 September 2022
2265